跳至主要内容
临床试验/NCT05318417
NCT05318417招募中不适用

A Post-approval, Prospective, Nonrandomized, Single-arm Multicenter Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness

Cochlear15 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年8月19日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Cochlear
入组人数
60
试验地点
15
主要终点
Change in sentence in noise scores at 12 months post-activation in the binaural (CI and normal hearing (NH)) listening condition compared to preoperatively in the best listening (NH alone or NH and hearing aid) condition in 3 speaker configurations.

研究概览

简要总结

The aim of the study is to assess the continued efficacy and safety of cochlear implantation in participants aged 5 years and above with Unilateral Hearing Loss (UHL)/Single Sided Deafness (SSD) supporting a change indication for use.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
5 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals 18 years or older (Group A)
  • Ear to be Implanted:
  • Severe sensorineural hearing loss (HL) defined as: Pure-tone average at 0.5, 1, 2, 4 kHz >80 dB HL ; Aided Consonant-Nucleus-Consonant Test (CNC) score ≤5% and
  • Normal Hearing Ear:
  • Normal or near normal hearing defined as an average of (0.5, 1, 2, 4kHz) ≤ 30 dB HL
  • Children 5 years to 17 years, 11 months (Group B)
  • Ear to be Implanted:
  • Severe sensorineural HL defined as: Pure-tone average at 0.5, 1, 2, 4 kHz >80 dB HL; Aided CNC score ≤5% and
  • Normal Hearing Ear:
  • Normal or near normal hearing defined as an average of (0.5, 1, 2, 4kHz) ≤ 30 dB HL
  • Previous experience with a current conventional treatment option for unilateral [SSD] HL (HA, bone-conduction device, or CROS technology), if no previous experience a minimum trial period of two weeks is required
  • English spoken as a primary language
  • Willing and able to provide written informed consent

排除标准

  • Ossification, abnormal cochlear nerve or any other cochlear anomaly that might prevent complete insertion of the electrode array
  • Previous cochlear implantation
  • Hearing loss of neural or central origin, including auditory neuropathy
  • Duration of profound sensorineural HL >10 years per self-report
  • Active / chronic middle-ear infection; conductive HL in either ear
  • Medical or psychological conditions that contraindicate undergoing surgery as determined by the Investigator
  • Unrealistic expectations on the part of the participant/family, regarding the possible benefits, risks, and limitations that are inherent as determined by the Investigator
  • Evidence of and/or suspected cognitive or developmental concern
  • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator
  • Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child or sibling
  • Cochlear employees or employees of Contract Research Organizations (CROs) or contractors engaged by Cochlear for the purposes of this investigation
  • Pregnant or breastfeeding women
  • Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device.

结局指标

主要结局

Change in sentence in noise scores at 12 months post-activation in the binaural (CI and normal hearing (NH)) listening condition compared to preoperatively in the best listening (NH alone or NH and hearing aid) condition in 3 speaker configurations.

时间窗: pre-implantation, 12 months post-activation

Measured with the Bamford-Kowal-Bench Sentence in Noise test (BKB-SIN). List of sentences are presented at 65 dBA with the level of noise varied stepwise at fixed signal to noise ratio to obtain a Speech Reception Threshold (SRT) where participants are able to repeat key words 50% of the time. Score range is not specified as metric is adaptive; lower scores indicate better performance. The 3 speaker configurations are: speech front/noise front; speech front/noise to NH ear; speech front/noise to poorer ear.

Number of procedure and device related adverse events classified by type, frequency and severity.

时间窗: 36 months post-activation

次要结局

  • Change in word recognition at 12 months post-activation in the CI alone condition compared to preoperative aided condition in the poorer hearing ear alone.(pre-implantation, 12 months post-activation)
  • Change in participant reported spatial hearing at 12 months post-activation compared to pre-operative ratings.(pre-implantation, 12 months post-activation)

研究者

发起方
Cochlear
申办方类型
Industry
责任方
Sponsor

研究点 (15)

Loading locations...

相似试验